Legis Daily

Chronic Kidney Disease Improvement in Research and Treatment Act of 2019

USA116th CongressS-1676| Senate 
| Updated: 5/23/2019
Benjamin L. Cardin

Benjamin L. Cardin

Democratic Senator

Maryland

Cosponsors (2)
Roy Blunt (Republican)Debbie Stabenow (Democratic)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Chronic Kidney Disease Improvement in Research and Treatment Act of 2019 This bill addresses Medicare coverage for and access to treatment for chronic kidney disease. Specifically, the bill modifies provisions related to coverage by (1) allowing certain Medicare beneficiaries who have End Stage Renal Disease to enroll in Medicare supplemental policies, and (2) establishing new Medicare payment structures for renal dialysis services. Among other changes, the bill (1) provides for alternative payment methodologies for certain new drugs, biologics, and devices that are renal dialysis services; (2) revises quality measures; (3) establishes an incentive payment methodology; and (4) increases access to kidney disease education services. In addition, the bill requires information sharing between hospitals and renal dialysis centers in some circumstances as well as federal studies on issues related to kidney disease, including the use of palliative care and ways to increase transplantation rates. The Department of Health and Human Services may also award National Health Services Corps scholarships and loan repayment to nephrology health professionals.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 23, 2019
Introduced in Senate
May 23, 2019
Read twice and referred to the Committee on Finance.
Jul 24, 2019

Latest Companion Bill Action

HR 116-3912
Referred to the Subcommittee on Health.
  • May 23, 2019
    Introduced in Senate


  • May 23, 2019
    Read twice and referred to the Committee on Finance.


  • July 24, 2019

    Latest Companion Bill Action

    HR 116-3912
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 116-3912: Chronic Kidney Disease Improvement in Research and Treatment Act
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth facilities and institutionsHealth information and medical recordsHealth personnelHealth technology, devices, suppliesHospital careMedical educationMedical researchMedicareMinority healthOrgan and tissue donation and transplantationStudent aid and college costs

Chronic Kidney Disease Improvement in Research and Treatment Act of 2019

USA116th CongressS-1676| Senate 
| Updated: 5/23/2019
Chronic Kidney Disease Improvement in Research and Treatment Act of 2019 This bill addresses Medicare coverage for and access to treatment for chronic kidney disease. Specifically, the bill modifies provisions related to coverage by (1) allowing certain Medicare beneficiaries who have End Stage Renal Disease to enroll in Medicare supplemental policies, and (2) establishing new Medicare payment structures for renal dialysis services. Among other changes, the bill (1) provides for alternative payment methodologies for certain new drugs, biologics, and devices that are renal dialysis services; (2) revises quality measures; (3) establishes an incentive payment methodology; and (4) increases access to kidney disease education services. In addition, the bill requires information sharing between hospitals and renal dialysis centers in some circumstances as well as federal studies on issues related to kidney disease, including the use of palliative care and ways to increase transplantation rates. The Department of Health and Human Services may also award National Health Services Corps scholarships and loan repayment to nephrology health professionals.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 23, 2019
Introduced in Senate
May 23, 2019
Read twice and referred to the Committee on Finance.
Jul 24, 2019

Latest Companion Bill Action

HR 116-3912
Referred to the Subcommittee on Health.
  • May 23, 2019
    Introduced in Senate


  • May 23, 2019
    Read twice and referred to the Committee on Finance.


  • July 24, 2019

    Latest Companion Bill Action

    HR 116-3912
    Referred to the Subcommittee on Health.
Benjamin L. Cardin

Benjamin L. Cardin

Democratic Senator

Maryland

Cosponsors (2)
Roy Blunt (Republican)Debbie Stabenow (Democratic)

Finance Committee

Health

Related Bills

  • HR 116-3912: Chronic Kidney Disease Improvement in Research and Treatment Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth facilities and institutionsHealth information and medical recordsHealth personnelHealth technology, devices, suppliesHospital careMedical educationMedical researchMedicareMinority healthOrgan and tissue donation and transplantationStudent aid and college costs